Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: Adherence, persistence, healthcare utilization and costs

Current Medical Research and Opinion

Volumn 31, Issue 12, 2015, Pages 2287-2296

  Machnicki, G ^a   Ong, S H ^b   Chen, W ^c   Wei, Z J ^c   Kahler, K H ^b  

^a Medtronic Latin America   (Argentina)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Novartis Pharma Co Ltd Ltd   (China)

Author keywords

Adherence; Costs; Healthcare utilization; Hypertension; Persistence; Single pill combination

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VALSARTAN; ANTIHYPERTENSIVE AGENT; DRUG COMBINATION;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DEMOGRAPHY; DIABETES MELLITUS; DRUG COST; DYSLIPIDEMIA; EMERGENCY WARD; FEMALE; FREE COMBINATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; ICD-9; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PHARMACOLOGICAL PARAMETERS; PRESCRIPTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE PILL COMBINATION; SMOKING; DRUG COMBINATION; PATIENT ATTITUDE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DRUG COMBINATIONS; FEMALE; HOSPITALIZATION; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; VALSARTAN;

EID: 84955739473     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1098598     Document Type: Article

References (23)

1. World Health Organisation (WHO). A global brief on hypertension. Silent killer, global public health crisis. 2013
2. Valderrama AL, Gillespie C, King SC, et al. Vital signs: Awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010. Morbid Mortal Wkly Rep 2012;61:703-9
3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357
4. Baser O, Andrews LM, Wang L, Xie L. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. J Med Econ 2011;14:576-83
5. NICE Clinical Guideline. Management of hypertension in adults in primary care. Partial update of Clinical Guideline No. 18. NICE Clinical Guideline. National Institute of Health and Clinical Excellence, 2006;34
6. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20
7. Fung V, Huang J, Brand R, et al. Hypertension treatment in a medicare population: Adherence and systolic blood pressure control. Clin Ther 2007;29:972-84
8. Yang W, Chang J, Kahler KH, et al. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr Med Res Opin 2010;26:2065-76
9. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens 2010;4:42-50
10. Gradman AH. Rationale for triple-combination therapy for management of high blood pressure. J Clin Hypertens (Greenwich) 2010;12:869-78
11. Hilleman DE. Adherence and health care costs with single-pill fixed-dose combinations in hypertension management. J Manag Care Pharm 2014;20:93-100
12. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404
13. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002;359:995-1003
14. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 2005;366:895-906
15. Flack JM, Calhoun DA, Satlin L, et al. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: The EX-STAND study. J Hum Hypertens 2009;23:479-89
16. Hess G, Hill J, Lau H, et al. Medication utilization patterns and hypertensionrelated expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. Phys Ther 2008;33:652-66
17. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-605
18. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
19. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: A meta-analysis. Am J Med 2007;120:713-19
20. Sherrill B, Halpern M, Khan S, et al. Single-pill vs free-equivalent combination therapies for hypertension: A meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich) 2011;13:898-909
21. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 2000;9(9 Suppl):2-6
22. Jackson KC, Sheng X, Nelson RE, et al. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther 2008;30:1558-63
23. Brixner DI, Jackson KC, Sheng X, et al. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008;24:2597-607